BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23399379)

  • 1. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
    Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
    Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
    Yousef YA; Al-Hussaini M; Mehyar M; Sultan I; Jaradat I; AlRawashdeh K; Khurma S; Deebajah R; Nawaiseh I
    Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
    Wilson MW; Rodriguez-Galindo C; Billups C; Haik BG; Laningham F; Patay Z
    Ophthalmology; 2009 Aug; 116(8):1558-63. PubMed ID: 19545904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
    Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
    Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
    J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.
    Chawla B; Sharma S; Sen S; Azad R; Bajaj MS; Kashyap S; Pushker N; Ghose S
    Ophthalmology; 2012 Apr; 119(4):850-6. PubMed ID: 22218144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.